Christian B. Poulsen

Roskilde, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: March 17, 2026

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

Journal: Journal of medicinal chemistry

Published: December 11, 2025

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine

Published: December 08, 2025

Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial.

Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial.

Journal: The Lancet. Haematology

Published: November 13, 2025

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial.

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial.

Journal: Blood

Published: October 22, 2025

Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials.

Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials.

Journal: European journal of haematology

Published: July 17, 2025

International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma.

International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 24, 2025

Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort study.

Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort study.

Journal: British journal of haematology

Published: June 10, 2025

Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study.

Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish nationwide population-based study.

Journal: British journal of haematology

Published: June 10, 2025

Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer.

Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancer.

Journal: HemaSphere

Published: March 27, 2025

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study.

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study.

Journal: Blood neoplasia

Published: February 25, 2025

Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study.

Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study.

Journal: British journal of haematology

Published: February 24, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026